News

Gilead Sciences reports profits but mixed revenue; Merck is in talks to acquire SpringWorks for $3.5 billion; measles cases ...
So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...
Germany's Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the ...
Scores of FDA employees are searching for an exit from an agency in turmoil, especially staffers tasked with reviewing drug ...
Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, ...
Barclays notes that SpringWorks Therapeutics’ Ogsiveo was included on today’s Committee for Medicinal Products for Human Use agenda, which could lead to a positive opinion for ...